Reducing unnecessary blood transfusions | RNA to treat prostate cancer | $5M for Black medical schools

  • ROCHESTER, MN—Eliminating unnecessary allogenic blood transfusions (when a donor and a recipient are not the same person) is critical when donor blood is in short supply. A Mayo Clinic study indicates that hospitals can reduce unnecessary blood transfusions and costs by implementing patient blood management programs. The data analytics study saw a risk reduction of 6% for receiving any transfusion during hospitalization.
  • ST. LOUIS, MO—A new study from Washington University School of Medicine in St. Louis indicates that RNA could be a new strategy to treat prostate cancer that has developed resistance to hormonal therapies. The researchers identified an RNA molecule, which they dubbed NXTAR, that suppresses prostate tumors.
  • CLEVELAND, OH—University Hospitals is deploying Interactions’ AI-powered virtual assistant to schedule appointments. The tool will seek to alleviate long wait times over the phone or accidental misdirections. It will also allow patients to update their profiles; schedule, reschedule or cancel appointments; or obtain appointment details without needing an agent.